Patterns of treatment and outcomes in real world elderly patients with metastatic oestrogen receptor positive (ER+) breast cancer receiving the CDK4/6 inhibitor Palbociclib and endocrine therapy. (October 2020) - Skrobo, D.; Prior, L.; Walshe, J.; Gullo, G.; Crown, J.